PIQTIRIS
DEAD

Serial Number

97273776

Owner

Blaze Bioscience, Inc.

Attorney

Connie Ellerbach

Filing Date

Feb 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PIQTIRIS Trademark

Serial Number: 97273776

PIQTIRIS is a trademark filed by Blaze Bioscience, Inc. on February 18, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Blaze Bioscience, Inc. (16 trademarks)

Seattle, WA 98109

Entity Type: 03

Trademark Details

Filing Date

February 18, 2022

Registration Date

Not Registered

Published for Opposition

April 4, 2023

Goods & Services

Diagnostic agents, preparations, and substances for medical purposes; Imaging and therapeutic agents for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; Preparations and substances for medical purposes for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; medical diagnostic reagents; reagents for medical use; imaging and detection agents for diagnosing and monitoring cancer, and oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders

Medical research; scientific research; product research and development; product development in the field of the detection, location, and treatment of diseases; design and development of therapies, diagnostic agents, imaging agents, and medical devices for detecting, locating, and treating cancer and other diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 16, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 16, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 1, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 1, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 1, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 1, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2024 EXRA
SOU EXTENSION 2 GRANTED
Apr 2, 2024 EX2G
SOU EXTENSION 2 FILED
Apr 2, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 8, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 6, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 6, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 6, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 28, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 28, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 28, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 28, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 27, 2023 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 24, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 24, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 24, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2022 NWOS
NEW APPLICATION ENTERED
Feb 22, 2022 NWAP